logo

Checkmate Pharmaceuticals, Inc. (CMPI)



Trade CMPI now with
  Date
  Headline
5/4/2021 7:36:41 AM Checkmate Pharma Doses Patient In Potential Registration Trial Of Vidutolimod In Anti-PD-1 Refractory Advanced Melanoma
4/19/2021 6:15:38 AM Checkmate Announces Initiation Of Dosing In Phase 2 Proof-of-concept Trial In Patients With HNSCC
12/8/2020 7:19:37 AM Checkmate Pharma Enters Clinical Collaboration Deal With Bristol Myers Squibb To Evaluate CMP-001 With Nivolumab
11/13/2020 7:26:16 AM Checkmate Q3 Net Loss And Comprehensive Loss $9.8 Mln